Ju Cao
Impact in
- Immunology top 2%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immune cells in cancer
- IL-33, ST2, and ILC Pathways
- Microbiology top 2%
Papers in ⓘ
- Epidemiology 47
- Pneumonia and Respiratory Infections 19
- Sepsis Diagnosis and Treatment 12
- Pneumocystis jirovecii pneumonia detection and treatment 10
- Immunology 42
- Immune Response and Inflammation 27
- Co-authors
- Fang Xu (17 shared papers)Yibing Yin (25 shared papers)Liping Zhang (15 shared papers)Xuemei Zhang (23 shared papers)Yibing Yin (20 shared papers)Shifeng Huang (8 shared papers)Yu Xiang (6 shared papers)Xingxing Yan (9 shared papers)
- Journals
- Clinical Immunology (6 papers)The Journal of Infectious Diseases (6 papers)International Immunopharmacology (6 papers)Vaccine (5 papers)Microbes and Infection (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ju Cao
95 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 1.0k
- Microbiology 189
- Epidemiology 870
- Critical Care and Intensive Care Medicine 120
- Molecular Medicine 99
Countries citing papers authored by Ju Cao
This map shows the geographic impact of Ju Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Cao more than expected).
Fields of papers citing papers by Ju Cao
This network shows the impact of papers produced by Ju Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Cao. The network helps show where Ju Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options Hit paper breakdown → | 2022 | 380 |
| 2 | 2012 | 114 | |
| 3 | 2013 | 75 | |
| 4 | 2016 | 60 | |
| 5 | 2007 | 59 | |
| 6 | 2014 | 52 | |
| 7 | 2013 | 50 | |
| 8 | 2016 | 49 | |
| 9 | 2011 | 48 | |
| 10 | 2018 | 48 | |
| 11 | 2015 | 47 | |
| 12 | 2009 | 46 | |
| 13 | 2013 | 45 | |
| 14 | 2009 | 43 | |
| 15 | 2007 | 43 | |
| 16 | 2018 | 42 | |
| 17 | 2013 | 40 | |
| 18 | 2018 | 39 | |
| 19 | 2017 | 36 | |
| 20 | Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion. | 2010 | 34 |
About Ju Cao
Ju Cao is a scholar working on Epidemiology, Immunology, Infectious Diseases, Molecular Biology and Microbiology, having authored 102 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immune Response and Inflammation (27 papers), Pneumonia and Respiratory Infections (19 papers), Sepsis Diagnosis and Treatment (12 papers), Bacterial Infections and Vaccines (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Antifungal resistance and susceptibility (8 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Intensive Care Unit Cognitive Disorders (7 papers). The work is most often cited by research in Immunology (1.0k citations), Microbiology (189 citations), Epidemiology (870 citations), Critical Care and Intensive Care Medicine (120 citations) and Molecular Medicine (99 citations). Ju Cao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Fang Xu, Yibing Yin, Liping Zhang, Xuemei Zhang, Yibing Yin, Shifeng Huang, Yu Xiang, Xingxing Yan, Shihui Lin and Zhixin Song. Their work appears in journals such as Clinical Immunology, The Journal of Infectious Diseases, International Immunopharmacology, Vaccine and Microbes and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.